Imatinib Tablet 400 mg

💊 DESCRIPTION

Imatinib (Imatinib mesylate) is an oral tyrosine kinase inhibitor (TKI) used primarily in the treatment of Philadelphia chromosome–positive (Ph+) cancers and tumors with specific genetic mutations.

  • Form: Film-coated tablet
  • Strength: 400 mg
  • Route: Oral
  • Indications:
    • Chronic Myeloid Leukemia (CML) – all phases (chronic, accelerated, blast crisis)
    • Acute Lymphoblastic Leukemia (ALL) – Ph+
    • Gastrointestinal Stromal Tumors (GIST) – c-KIT (CD117) positive
    • Myelodysplastic/Myeloproliferative disorders (MDS/MPD)
    • Hypereosinophilic syndrome / Chronic eosinophilic leukemia
    • Dermatofibrosarcoma protuberans (DFSP)

ADVANTAGES

  • Targeted therapy – selectively inhibits abnormal cancer-causing proteins
  • Highly effective in CML and GIST
  • Oral once-daily dosing is convenient
  • Generally well-tolerated with fewer systemic side effects than traditional chemotherapy
  • Has significantly improved survival rates in patients with CML

🌿 NATURE

  • Drug Class: Tyrosine kinase inhibitor
  • Mechanism of Action:
    • Blocks the BCR-ABL tyrosine kinase (Philadelphia chromosome fusion gene)
    • Inhibits c-KIT (GIST) and PDGFR tyrosine kinases
    • Prevents phosphorylation of proteins required for cancer cell proliferation and survival
    • Leads to apoptosis of malignant cells

⚠️ PRECAUTIONS

  • Hematologic toxicity: Risk of neutropenia, anemia, thrombocytopenia – regular CBC monitoring needed
  • Hepatotoxicity: Monitor liver function tests (LFTs)
  • Edema/Fluid retention: May cause swelling, weight gain, or pleural effusion
  • Gastrointestinal effects: Nausea, vomiting, diarrhea may occur
  • Dermatologic reactions: Rash, itching, skin pigmentation
  • Cardiac effects: Caution in patients with cardiac disease or risk factors
  • Pregnancy & Lactation: Contraindicated – teratogenic
  • CYP3A4 Interactions: Many drug interactions – avoid grapefruit juice, some antifungals, antiepileptics

🧊 STORAGE

  • Store at 20–25°C (68–77°F)
  • Protect from moisture and direct light
  • Keep in original container, tightly closed
  • Keep out of reach of children

👨‍⚕️ PATIENT ADVICE

  • Take once daily with a large glass of water and food to minimize gastric irritation
  • Do not crush, split, or chew the tablet
  • Take at the same time each day
  • Avoid grapefruit juice – it may affect drug metabolism
  • Inform doctor about all medications, including over-the-counter and herbal
  • Report any signs of:
    • Bleeding or bruising
    • Fever or signs of infection
    • Jaundice (yellowing of eyes/skin)
    • Sudden weight gain or swelling
  • Use contraception – avoid pregnancy during and for at least 1 month after stopping treatment
  • Regular blood and organ function tests are essential

📦 PACKAGING

  • Primary Packaging:
    • HDPE bottles or blister strips containing 400 mg film-coated tablets
    • Tablet usually marked/imprinted (e.g., “400”)
  • Secondary Packaging:
    • Outer carton with patient information leaflet
    • Labeled with:
      • Strength (400 mg)
      • Batch number, manufacturing & expiry dates
      • Storage instructions
      • Manufacturer’s details
      • “Cytotoxic – handle with care” marking in some cases

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button